16 results for author:"Diaz-Rubio E." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin. Ruiz de Garibay G., Gutierrez-Enriquez S., Garre P., Bonache S., Romero A., Palomo L., Sanchez de Abajo A., Benitez J., Balmana J., Perez-Segura P. et al. Breast Cancer Res. Treat. 133:273-283(2012) · Mapped (18) |
| Topoisomerase 2 alpha: a real predictor of anthracycline efficacy? Romero A., Caldes T., Diaz-Rubio E., Martin M. Clin Transl Oncol 14:163-168(2012) · Mapped (1) |
| Assessment of Topoisomerase II alpha status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization. Romero A., Martin M., Cheang M.C., Lopez Garcia-Asenjo J.A., Oliva B., He X., de la Hoya M., Garcia Saenz J.A., Arroyo Fernandez M., Diaz Rubio E. et al. Am. J. Pathol. 178:1453-1460(2011) · Mapped (1) |
| Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC). Garre P., Briceno V., Xicola R.M., Doyle B.J., de la Hoya M., Sanz J., Llovet P., Pescador P., Puente J., Diaz-Rubio E. et al. Clin. Cancer Res. 17:1701-1712(2011) · Mapped (27) |
| A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome. Caronia D., Martin M., Sastre J., de la Torre J., Garcia-Saenz J.A., Alonso M.R., Moreno L.T., Pita G., Diaz-Rubio E., Benitez J. et al. Clin. Cancer Res. 17:2006-2013(2011) · Mapped (3) |
| Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Garre P., Perez-Segura P., Diaz-Rubio E., Caldes T., de la Hoya M. Nat. Genet. 42:817-8; author reply 2010:818-818(2010) · Mapped (2) |
| MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. Ortega P., Moran A., Fernandez-Marcelo T., De Juan C., Frias C., Lopez-Asenjo J.A., Sanchez-Pernaute A., Torres A., Diaz-Rubio E., Iniesta P. et al. Int. J. Oncol. 36:1209-1215(2010) · Mapped (8) |
| Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Milne R.L., Osorio A., Ramon y Cajal T., Baiget M., Lasa A., Diaz-Rubio E., de la Hoya M., Caldes T., Teule A., Lazaro C. et al. Breast Cancer Res. Treat. 119:221-232(2010) · Mapped (18) |
| Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. Martinez-Balibrea E., Abad A., Aranda E., Sastre J., Manzano J.L., Diaz-Rubio E., Gomez-Espana A., Aparicio J., Garcia T., Maestu I. et al. Eur. J. Cancer 44:1229-1237(2008) · Mapped (17) |
| Molecular haplotyping of tandem single nucleotide polymorphisms by allele-specific PCR. Canadas C., Sanchez-de-Abajo A., Fernandez J.M., Martin M., Diaz-Rubio E., Caldes T., de la Hoya M. Anal. Biochem. 364:153-158(2007) · Mapped (13) |
| Characterization of MDGA1, a novel human glycosylphosphatidylinositol-anchored protein localized in lipid rafts. Diaz-Lopez A., Rivas C., Iniesta P., Moran A., Garcia-Aranda C., Megias D., Sanchez-Pernaute A., Torres A., Diaz-Rubio E., Benito M. et al. |
| Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both. de la Hoya M., Fernandez J.M., Tosar A., Godino J., Sanchez de Abajo A., Vidart J.A., Perez-Segura P., Diaz-Rubio E., Caldes T. JAMA 290:929-931(2003) · Mapped (35) |
| Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors. De Juan C., Iniesta P., Gonzalez-Quevedo R., Moran A., Sanchez-Pernaute A., Torres A.J., Balibrea J.L., Diaz-Rubio E., Cruces J., Benito M. |
| Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Caldes T., Godino J., de la Hoya M., Garcia Carbonero I., Perez Segura P., Eng C., Benito M., Diaz-Rubio E. Int. J. Cancer 98:774-779(2002) · Mapped (42) |
| Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. de la Hoya M., Osorio A., Godino J., Sulleiro S., Tosar A., Perez-Segura P., Fernandez C., Rodriguez R., Diaz-Rubio E., Benitez J. et al. Int. J. Cancer 97:466-471(2002) · Mapped (18) |
| Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain. Godino J., de La Hoya M., Diaz-Rubio E., Benito M., Caldes T. |